Background: To evaluate bone-mineral-density-BMD determined by dual-energy X-ray absorptiometry-DEXA and bone turnover markers in chronic-kidney-disease-CKD patients. Method: An observational-clinical study of all patients who were scanned by DEXA-scan in 2018. All patients with low-bone-density or osteoporosis-based on World-Health-Organization-WHO definition were included. Results: 505 patients with abnormal-BMD, 87.3% were in early-stage CKD-stage I - II, 8.5% were in CKD-stage III - V and 4.2% did not have renal tests. 95 (18.8%) were male with a mean age of 57.0 years and 410 (81.2%) were females with a mean age of 55.8 years. Patients of ≥65 years had lower T-score than those who were younger than 65 years-old. Among CKD patients, those with late-CKD (stage III - V) had less BMD-measurements and lower T-score than those with early-CKD (stage I - II). A significant positive correlation exists between parathyroid hormone-PTH-level and the lower T-score. Female had a worse T-score at the lumbar-region whereas male had a worse T-score at the femoral-region. There was no significant difference between males and females for the T-score at hip-region. Conclusion: We observed a distribution of abnormal BMD among different age, sex and CKD groups. Measurements of BMD by DEXA might be a useful test to diagnose osteoporosis in CKD patients. Femoral and total hip areas were more affected, however DEXA might not be able to detect osteoporosis in the lumbar area of CKD patients. T-scores are lower in patients with more severe CKD and lower in elderly patients. PTH level is associated proportionally to the degree of bone loss. Early intervention and proper management must be implemented early among CKD patients with multidisciplinary team approach strategy. More studies are needed to determine if DEXA techniques are enough to distinguish the quantity of bone loss between different stages of CKD.
Aggarwal, H.K., Jain, D., Yadav, S. and Kaverappa, V. (2013) Bone Mineral Density in Patients with Predialysis Chronic Kidney Disease. Renal Failure, 35, 1105-1111. https://doi.org/10.3109/0886022X.2013.815102
Bezerra de Carvalho, K.S., Vasco, R.F.V., Custodio, M.R., Jorgetti, V., Moyses, R.M.A. and Elias, R.M. (2019) Chronic Kidney Disease Is Associated with Low BMD at the Hip but Not at the Spine. Osteoporosis International, 30, 1015-1023. https://doi.org/10.1007/s00198-019-04864-4
Miller, P.D. (2014) Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management. American Journal of Kidney Diseases, 64, 290-304.
Miller, P.D. (2014) Chronic Kidney Disease and the Skeleton. Bone Research, 2, Article No. 14044. https://doi.org/10.1038/boneres.2014.44
Pan, B.L. and Loke, S.S. (2018) Chronic Kidney Disease Associated with Decreased Bone Mineral Density, Uric Acid and Metabolic Syndrome. PLoS ONE, 13, e0190985. https://doi.org/10.1371/journal.pone.0190985
Hou, Y.C., Lu, C.L. and Lu, K.C. (2018) Mineral Bone Disorders in Chronic Kidney Disease. Nephrology, 23, 88-94. https://doi.org/10.1111/nep.13457
Iwasaki, Y., Kazama, J.J. and Fukagawa, M. (2017) Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. BioMed Research International, 2017, Article ID: 3485785. https://doi.org/10.1155/2017/3485785
McNerny, E.M.B. and Nickolas, T.L. (2017) Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics. Current Osteoporosis Reports, 15, 207-213. https://doi.org/10.1007/s11914-017-0366-z
Bacchetta, J., Boutroy, S., Juillard, L., Vilayphiou, N., Guebre-Egziabher, F., Pelletier, S., et al. (2009) Bone Imaging and Chronic Kidney Disease: Will High-Resolution Peripheral Tomography Improve Bone Evaluation and Therapeutic Management? Journal of Renal Nutrition, 19, 44-49.
Carter, J.L., O’Riordan, S.E., Eaglestone, G.L., Delaney, M.P. and Lamb, E.J. (2008) Bone Mineral Metabolism and Its Relationship to Kidney Disease in a Residential Care Home Population: A Cross-Sectional Study. Nephrology Dialysis Transplantation, 23, 3554-3565. https://doi.org/10.1093/ndt/gfn302
Ketteler, M., Block, G.A., Evenepoel, P., Fukagawa, M., Herzog, C.A., McCann, L., et al. (2017) Executive Summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What’s Changed and Why It Matters. Kidney International, 92, 26-36.
Ketteler, M., Elder, G.J., Evenepoel, P., Ix, J.H., Jamal, S.A., Lafage-Proust, M.H., et al. (2015) Revisiting KDIGO Clinical Practice Guideline on Chronic Kidney Disease-Mineral and Bone Disorder: A Commentary from a Kidney Disease: Improving Global Outcomes Controversies Conference. Kidney International, 87, 502-528.
Bover, J., Urena-Torres, P., Laiz Alonso, A.M., Torregrosa, J.V., Rodriguez-Garcia, M., Castro-Alonso, C., et al. (2019) Osteoporosis, Bone Mineral Density and CKD-MBD (II): Therapeutic Implications. Nefrología, 39, 227-242. https://doi.org/10.1016/j.nefro.2018.10.009
Damasiewicz, M.J. and Nickolas, T.L. (2018) Rethinking Bone Disease in Kidney Disease. JBMR Plus, 2, 309-322. https://doi.org/10.1002/jbm4.10117
Khairallah, P. and Nickolas, T.L. (2018) Updates in CKD-Associated Osteoporosis. Current Osteoporosis Reports, 16, 712-723. https://doi.org/10.1007/s11914-018-0491-3
Bover, J., Urena-Torres, P., Torregrosa, J.V., Rodriguez-Garcia, M., Castro-Alonso, C., Gorriz, J.L., et al. (2018) Osteoporosis, Bone Mineral Density and CKD-MBD Complex (I): Diagnostic Considerations. Nefrología, 38, 476-490. https://doi.org/10.1016/j.nefro.2017.12.006
Connelly, K., Collister, D. and Tangri, N. (2018) Fracture Risk and Treatment in Chronic Kidney Disease. Current Opinion in Nephrology and Hypertension, 27, 221-225. https://doi.org/10.1097/MNH.0000000000000411
Nickolas, T.L. and Jamal, S.A. (2015) Bone Kidney Interactions. Reviews in Endocrine and Metabolic Disorders, 16, 157-163.
Chiang, C. (2017) The Use of Bone Turnover Markers in Chronic Kidney Disease-Mineral and Bone Disorders. Nephrology, 22, 11-13. https://doi.org/10.1111/nep.13014
Robling, A.G., Kedlaya, R., Ellis, S.N., Childress, P.J., Bidwell, J.P., Bellido, T., et al. (2011) Anabolic and Catabolic Regimens of Human Parathyroid Hormone 1-34 Elicit Bone- and Envelope-Specific Attenuation of Skeletal Effects in Sost-Deficient Mice. Endocrinology, 152, 2963-2975. https://doi.org/10.1210/en.2011-0049
Siddiqui, J.A., Johnson, J., Le Henaff, C., Bitel, C.L., Tamasi, J.A. and Partridge, N.C. (2017) Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism. Scientific Reports, 7, Article No. 15300. https://doi.org/10.1038/s41598-017-15563-7
Al Alawi, I.H., Al Salmi, I., Al Mawali, A. and Sayer, J.A. (2017) Kidney Disease in Oman: A View of the Current and Future Landscapes. Iranian Journal of Kidney Diseases, 11, 263-270.
Al Ismaili, F., Al Salmi, I., Al Maimani, Y., Metry, A.M., Al Marhoobi, H., Hola, A., et al. (2017) Epidemiological Transition of End-Stage Kidney Disease in Oman. Kidney International Reports, 2, 27-35.
Kanis, J.A. (1995) The Use of Alfacalcidol in the Prevention of Bone Disease in Early renal Failure. Nephrology Dialysis Transplantation, 10, 23-28. https://doi.org/10.1093/ndt/10.supp4.23
Kanis, J.A. (1999) Vitamin D Analogs: From Renal Bone Disease to Osteoporosis. Kidney International Supplements, 73, S77-S81.
Lewiecki, E.M. (2012) Preventing Fractures in Diabetic Dialysis Patients. International Journal of Endocrinology and Metabolism, 10, 640-641.
Abrahamsen, B., Ernst, M.T., Smith, C.D., Nybo, M., Rubin, K.H., Prieto-Alhambra, D., et al. (2020) The Association between Renal Function and BMD Response to Bisphosphonate Treatment: Real-World Cohort Study Using Linked National Registers. Bone, 137, Article ID: 115371. https://doi.org/10.1016/j.bone.2020.115371
Kanis, J.A., McCloskey, E.V. and Beneton, M.N. (1997) Vitamin D and Analogues in Renal Bone Disease and Implications for Osteoporosis. Osteoporosis International, 7, 179-183. https://doi.org/10.1007/BF03194368
Cortet, B. (2011) Osteoporosis Medications and Renal Failure. Joint Bone Spine, 78, 228-229. https://doi.org/10.1016/j.jbspin.2010.11.014
Sugatani, T. (2018) Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. International Journal of Molecular Sciences, 19, Article No. 2490. https://doi.org/10.3390/ijms19092490
Blomquist, G.A., Davenport, D.L., Mawad, H.W., Monier-Faugere, M.C. and Malluche, H.H. (2016) Diagnosis of Low Bone Mass in CKD-5D Patients. Clinical Nephrology, 85, 77-83. https://doi.org/10.5414/CN108708
Fidan, N., Inci, A., Coban, M., Ulman, C. and Kursat, S. (2016) Bone Mineral Density and Biochemical Markers of Bone Metabolism in Predialysis Patients with Chronic Kidney Disease. Journal of Investigative Medicine, 64, 861-866.
Leonard, M.B., Wehrli, F.W., Ziolkowski, S.L., Billig, E., Long, J., Nickolas, T.L., et al. (2019) A Multi-Imaging Modality Study of Bone Density, Bone Structure and the Muscle-Bone Unit in End-Stage renal Disease. Bone, 127, 271-279. https://doi.org/10.1016/j.bone.2019.05.022
Sharma, A.K., Toussaint, N.D., Elder, G.J., Masterson, R., Holt, S.G., Robertson, P.L., et al. (2018) Magnetic Resonance Imaging Based Assessment of Bone Microstructure as a Non-Invasive Alternative to Histomorphometry in Patients with Chronic Kidney Disease. Bone, 114, 14-21. https://doi.org/10.1016/j.bone.2018.05.029
Greenwood, C., Clement, J., Dicken, A., Evans, J.P., Lyburn, I., Martin, R.M., et al. (2016) Towards New Material Biomarkers for Fracture Risk. Bone, 93, 55-63. https://doi.org/10.1016/j.bone.2016.09.006
Salas-Ramirez, M., Tran-Gia, J., Gbureck, U., Kosmala, A. and Lassmann, M. (2019) Quantification of the Trabecular Bone Volume Fraction for Bone Marrow Dosimetry in Molecular Radiotherapy by Using a Dual-Energy (SPECT/)CT. Physics in Medicine & Biology, 64, Article ID: 205014. https://doi.org/10.1088/1361-6560/ab4476
Jorgensen, H.S., Winther, S., Bottcher, M., Hauge, E.M., Rejnmark, L., Svensson, M., et al. (2017) Bone Turnover Markers Are Associated with Bone Density, but Not with Fracture in End Stage Kidney Disease: A Cross-Sectional Study. BMC Nephrology, 18, Article No. 284. https://doi.org/10.1186/s12882-017-0692-5
Valkovsky, I., Olsanska, R., Tvrdik, J., Martinek, A., Svagera, Z., Pernicova, M., et al. (2015) Evaluation of Biochemical Markers and Bone Mineral Density in Patients with Chronic Kidney Disease Stage 5D at the Start of Hemodialysis Treatment. Biomedical Papers, 159, 93-99.
Miller, P.D. (2011) The Kidney and Bisphosphonates. Bone, 49, 77-81. https://doi.org/10.1016/j.bone.2010.12.024
Shigematsu, T., Sonou, T., Ohya, M., Yokoyama, K., Yoshida, H., Yokoo, T., et al. (2017) Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease. Contributions to Nephrology, 189, 169-177. https://doi.org/10.1159/000452310
Shindyapina, A.V., Mkrtchyan, G.V., Gneteeva, T., Buiucli, S., Tancowny, B., Kulka, M., et al. (2014) Mineralization of the Connective Tissue: A Complex Molecular Process Leading to Age-Related Loss of Function. Rejuvenation Research, 17, 116-133. https://doi.org/10.1089/rej.2013.1475
Chao, C.T., Yang, R.S., Huang, W.J., Tsai, K.S. and Chan, D.D. (2019) Risk Factors for Poor Functional Recovery, Mortality, Recurrent Fractures, and Falls Among Patients Participating in a Fracture Liaison Service Program. Journal of the American Medical Directors Association, 20, 1129-1136.e1.
Yenchek, R.H., Ix, J.H., Shlipak, M.G., Bauer, D.C., Rianon, N.J., Kritchevsky, S.B., et al. (2012) Bone Mineral Density and Fracture Risk in Older Individuals with CKD. Clinical Journal of the American Society of Nephrology, 7, 1130-1136.
Torres, P.A.U. and Cohen-Solal, M. (2017) Evaluation of Fracture Risk in Chronic Kidney Disease. Journal of Nephrology, 30, 653-661. https://doi.org/10.1007/s40620-017-0398-6
Curtis, J.R., Ewing, S.K., Bauer, D.C., Cauley, J.A., Cawthon, P.M., Barrett-Connor, E., et al. (2012) Association of Intact Parathyroid Hormone Levels with Subsequent Hip BMD Loss: The Osteoporotic Fractures in Men (MrOS) Study. The Journal of Clinical Endocrinology & Metabolism, 97, 1937-1944. https://doi.org/10.1210/jc.2011-2431